Article Details

aTyr Pharma Presents Preclinical Research Highlighting Mechanistic Insights into Tumor Inhibitory ...

Retrieved on: 2021-05-19 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

aTyr Pharma Presents Preclinical Research Highlighting Mechanistic Insights into Tumor Inhibitory .... View article details on hiswai:

Excerpt

ATYR2810 is a fully humanized monoclonal antibody that is designed to specifically and functionally block the interaction between NRP2 and one of ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up